262 related articles for article (PubMed ID: 27898730)
1. Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Saito K; Ueta M; Maekawa K; Sotozono C; Kinoshita S; Saito Y
PLoS One; 2016; 11(11):e0167402. PubMed ID: 27898730
[TBL] [Abstract][Full Text] [Related]
2. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
Ueta M
Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
[No Abstract] [Full Text] [Related]
3. Genetic Predisposition to Stevens-Johnson Syndrome With Severe Ocular Surface Complications.
Ueta M
Cornea; 2015 Nov; 34 Suppl 11():S158-65. PubMed ID: 26448174
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
[TBL] [Abstract][Full Text] [Related]
5. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
[TBL] [Abstract][Full Text] [Related]
6. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
De Rojas MV; Dart JK; Saw VP
Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
[TBL] [Abstract][Full Text] [Related]
7. Relationship between Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Kwan J; Ahmed H; Ponsetto MK; Succar T; Chodosh J; Saeed HN
Ocul Immunol Inflamm; 2023 Jul; 31(5):900-904. PubMed ID: 35486647
[TBL] [Abstract][Full Text] [Related]
8. Clinical parameters and biological markers associated with acute severe ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Panpruk R; Puangsricharern V; Klaewsongkram J; Rerknimitr P; Kittipibul T; Chongpison Y; Buranapraditkun S
Sci Rep; 2021 Oct; 11(1):20275. PubMed ID: 34642376
[TBL] [Abstract][Full Text] [Related]
9. Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population.
Wakamatsu TH; Ueta M; Tokunaga K; Okada Y; Loureiro RR; Costa KA; Sallum JMF; Milhomens JA; Inoue C; Sotozono C; Gomes JÁP; Kinoshita S
JAMA Ophthalmol; 2017 Apr; 135(4):355-360. PubMed ID: 28278336
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
11. Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand.
Jongkhajornpong P; Lekhanont K; Pisuchpen P; Chantaren P; Puangsricharern V; Prabhasawat P; Suphapeetiporn K; Kinoshita S; Ueta M
Br J Ophthalmol; 2018 Sep; 102(9):1303-1307. PubMed ID: 29706602
[TBL] [Abstract][Full Text] [Related]
12. Severe Physical Complications among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Olteanu C; Shear NH; Chew HF; Hashimoto R; Alhusayen R; Whyte-Croasdaile S; Finkelstein Y; Burnett M; Ziv M; Sade S; Jeschke MG; Dodiuk-Gad RP
Drug Saf; 2018 Mar; 41(3):277-284. PubMed ID: 29052094
[TBL] [Abstract][Full Text] [Related]
13. Human leucocyte antigen association of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications in Han Chinese.
Ma KS; Chung WH; Hsueh YJ; Chen SY; Tokunaga K; Kinoshita S; Ma DHK; Ueta M
Br J Ophthalmol; 2022 May; 106(5):610-615. PubMed ID: 33441319
[TBL] [Abstract][Full Text] [Related]
14. Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement.
Ueta M; Kaniwa N; Sotozono C; Tokunaga K; Saito Y; Sawai H; Miyadera H; Sugiyama E; Maekawa K; Nakamura R; Nagato M; Aihara M; Matsunaga K; Takahashi Y; Furuya H; Muramatsu M; Ikezawa Z; Kinoshita S
Sci Rep; 2014 Apr; 4():4862. PubMed ID: 24781922
[TBL] [Abstract][Full Text] [Related]
15. Specific association of the rs6500265 and rs9933632 single-nucleotide polymorphisms in Japanese patients with antipyretic analgesic-related Stevens-Johnson syndrome and toxic epidermal necrolysis with severe ocular involvements.
Okamoto-Uchida Y; Nakamura R; Matsunaga K; Aihara M; Saito Y
Pharmacogenet Genomics; 2018 Mar; 28(3):95-98. PubMed ID: 29239905
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series.
Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM
Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M
Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin as a diagnostic indicator for systemic bacterial infections in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Wang Q; Tian XB; Liu W; Zhang LX
J Dermatol; 2018 Aug; 45(8):989-993. PubMed ID: 29897140
[TBL] [Abstract][Full Text] [Related]
20. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R
Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
